CoChat

Neurocognitive Impairment in mdx Mice

Comim, Clarissa M., Ventura, Letícia, Freiberger, Viviane, Dias, Paula, Bragagnolo, Daiane, Dutra, Matheus L., Amaral, Ricardo A., Camargo-Fagundes, Ana Lucia S., Reis, Patrícia A., Castro-Faria-Neto, Hugo C., Vainzof, Mariz, Rosa, Maria I. · 2019 · Molecular Neurobiology
Cited by 27

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-019-1573-7

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 48

  1. Ram S (2017) Global muscular dystrophy research: a 25-year bibliometric perspective. Neurol India 65:993–1000 · DOI
  2. Knuesel I, Bornhauser BC, Zuellig RA, Heller F, Schaub MC, Fritschy JM (2000) Differential expression of utrophin and dystrophin in CNS neurons: an insitu hybridization and immunohistochemical study. J Comp Neurol 422:594–611 · DOI
  3. Rae MG, O’Malley D (2016) Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. J Neurophysiol 116:1304–1315 · DOI
  4. Miranda R, Laroche S, Vaillend C (2016) Reduced neuronal density in the CA1 anterodorsal hippocampus of the mdx mouse. Neuromuscul Disord 26:775–781 · DOI
  5. Comim CM, Cassol OJ Jr, Constantino LC, Constantino LS, Petronilho F, Tuon L, Vainzof M, Dal-Pizzol F et al (2009) Oxidative variables and antioxidant enzymes activities in the mdx mouse brain. Neurochem Int 55:802–805 · DOI
  6. Tuon L, Comim CM, Fraga DB, Scaini G, Rezin GT, Baptista BR, Streck EL, Vainzof M et al (2010) Mitochondrial respiratory chain and creatine kinase activities in mdx mouse brain. Muscle Nerve 41:257–260 · DOI
  7. Vaillend C, Chaussenot R (2017) Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum Mol Genet 26:1041–1055
  8. Comim CM, Moraz T, Abreu I, Fraga DB, Ghedim FV, Mildner N, Tuon L, Vainzof M et al (2011) Reduction of acethylcolinesterase activity in the brain of mdx mice. Neuromuscul Disord 21:359–362 · DOI · Paper page
  9. Comim CM, Hoepers A, Ventura L, Freiberger V, Dominguini D, Mina F, Mendonça BP, Scaini G et al (2016) Activity of Krebs cycle enzymes in mdx mice. Muscle Nerve 53:91–95 · DOI
  10. de Brouwer AP, Nabuurs SB, Verhaart IE, Oudakker AR, Hordijk R, Yntema HG, Hordijk-Hos JM, Voesenek K et al (2014) A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy. Eur J Hum Genet 22:480–485 · DOI
  11. Snow WM, Anderson JE, Jakobson LS (2013) Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav Rev 37:743–752 · DOI · Paper page
  12. Piccini G, Gazzellini S, D’Amico A, Pane M, Castelli E, Vicari S (2014) Developmental lag of visuospatial attention in Duchenne muscular dystrophy. Res Dev Disabil 14(36C):55–61
  13. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, Turconi AC, Lai M et al (2000) Loss of Dp140 dystrophin. Isoform and intellectual impairment in Duchenne dystrophy. Neurology 55:559–564 · DOI
  14. Nardes F, Araujo AP, Ribeiro MG (2012) Mental retardation in Duchenne muscular dystrophy. J Pediatr 88:6–16 · DOI
  15. Muntoni F, Mateddu A, Serra G (1991) Passive avoidance behaviour deficit in the mdx mouse. Neuromuscul Disord 1:121–123 · DOI · Paper page
  16. de Paepe B, De Bleecker JL (2013) Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy. Mediat Inflamm 1:540370
  17. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J et al (2002) A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11:263–272 · DOI · Paper page
  18. Comim CM, Mathia GB, Hoepers A, Tuon L, Kapczinski F, Dal-Pizzol F, Quevedo J, Rosa MI (2015) Neurotrophins, cytokines, oxidative parameters and functionality in progressive muscular dystrophies. An Acad Bras Cienc 87:1809–1818 · DOI
  19. Kuru S, Inukai A, Kato T, Liang Y, Kimura S, Sobue G (2003) Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol 105:217–224 · DOI
  20. Porreca E, Guglielmi MD, Uncini A, Di Gregorio P, Angelini A, Di Febbo C, Pierdomenico SD, Baccante G et al (1999) Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. Thromb Haemost 81:543–546 · DOI
  21. Evans NP, Misyak SA, Robertson JL, Bassaganya-Riera J, Grange RW (2009) Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention. PM R 1:755–768 · DOI
  22. Nico B, Roncali L, Mangieri D, Ribatti D (2005) Blood-brain barrier alterations in MDX mouse, an animal model of the Duchenne muscular dystrophy. Curr Neurovasc Res 2:47–54 · DOI
  23. Nico B, Corsi P, Ria R, Crivellato E, Vacca A, Roccaro AM, Mangieri D, Ribatti D et al (2006) Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse. Neuroscience 140:835–848 · DOI
  24. Pozzi D, Menna E, Canzi A, Desiato G, Mantovani C, Matteoli M (2018) The communication between the immune and nervous systems: the role of IL-1β in synaptopathies. Front Mol Neurosci 11:111 · DOI
  25. De Boer SF, Koolhaas JM (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463:145–161 · DOI · Paper page
  26. Cohena SJ, Stackman RW Jr (2015) Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav Brain Res 285:105–117 · DOI · Paper page
  27. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167 · DOI · Paper page
  28. Rickels K, Schweizer EE (1987) Current pharmacotherapy in anxiety and panic. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp. 1193–1203
  29. Porsolt RD (1979) Animal model of depression. Biomedicine 30:139–140
  30. Einat H, Clenet F, Shaldubina A, Belmaker RH, Bourin M (2001) The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors. Behav Brain Res 118:77–83 · DOI
  31. Hinton VJ, De Vivo BC, Nereo NE (2000) Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurolog 54:2127–2132 · DOI · Paper page
  32. Billard C, Gillet P, Barthez M-A (1998) Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol 40:12–20 · DOI
  33. Roccella M, Pace R, De Gregorio MT (2003) Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy. Minerva Pediatr 55:267–276
  34. Gold PE (1986) The use of avoidance training in studies of modulation of memory storage. Behav Neural Biol 46:87–98 · DOI · Paper page
  35. Doorenweerd N, Straathof CS, Dumas EM, Spitali P, Ginjaar IB, Wokke BH, Schrans DG, van den Bergen JC et al (2014) Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann Neurol 76:403–411 · DOI · Paper page
  36. Kogelman B, Khmelinskii A, Verhaart I, Vliet LV, Bink DI, Aartsma-Rus A, Putten MV, Weerd LV (2018) Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy. PLoS One 13:e0194636 · DOI
  37. Aranmolate A, Tse N, Colognato H (2017) Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy. BMC Neurosci 18:63 · DOI
  38. Comim CM, Tuon L, Stertz L, Vainzof M, Kapczinski F, Quevedo J (2009) Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice. Neurosci Lett 459:66–68 · DOI
  39. Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A (2015) Cognitive and neurobehavioral profile in boys with Duchenne muscular dystrophy. J Child Neurol 30:1472–1482 · DOI · Paper page
  40. Nuyen J, Volkers A, Verhaak P, Schellevis F, Groenewegen P, Van den Bos G (2005) Accuracy of diagnosing depression in primary care: the impact of chronic somatic and psychiatric co-morbidity. Psychol Med 35:1185–1195 · DOI
  41. Pangalila RF, van den Bos GA, Bartels B, Bergen M, Stam HJ, Roebroeck ME (2015) Prevalence of fatigue, pain, and affective disorders in adults with Duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil 96:1242–1247 · DOI
  42. Grounds MD, Torrisi J (2004) Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 18:676–682 · DOI · Paper page
  43. Vellosa JCR, Parabocz GC, Manente FA, Ribas JT, Lima LW (2013) Alterações metabólicas e inflamatórias em condições de estresse oxidativo. Rev Ciênc Fram Básica Apl 34:304–312
  44. Alder J, Kanki H, Valtorta F, Greengard P, Poo MM (1995) Overexpression of synaptophysin enhances neurotransmitter secretion at Xenopus neuromuscular synapses. J Neurosci 15:511–519 · DOI · Paper page
  45. Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases—what is the evidence? Front Neurosci 9:469 · DOI · Paper page
  46. Allen DG, Gervasio OL, Yeung EW, Whitehead NP (2010) Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 88:83–91 · DOI · Paper page
  47. van Westering TL, Betts CA, Wood MJ (2015) Current understanding of molecular pathology and treatment of cardiomyopathy in Duchenne muscular dystrophy. Molecules 20:8823–8855 · DOI
  48. Schubert D, Piasecki D (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J Neurosci 21:7455–7462 · DOI · Paper page

Cited by

See all 27

Metadata

Authors
Comim, C. M., Ventura, L., Freiberger, V., Dias, P., Bragagnolo, D., Dutra, M. L., Amaral, R. A., Camargo-Fagundes, A. L. S., Reis, P. A., Castro-Faria-Neto, H. C., Vainzof, M., & Rosa, M. I.
Venue
Molecular Neurobiology
Published
2019-05-10
Volume
56
Issue
11
Pages
7608-7616
ISSN
  • 0893-7648
  • 1559-1182
Cited by
27
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurocognitive Impairment in mdx Mice. https://app.cochat.ai/papers/10.1007/s12035-019-1573-7
The paper
Comim, C. M., Ventura, L., Freiberger, V., Dias, P., Bragagnolo, D., Dutra, M. L., Amaral, R. A., Camargo-Fagundes, A. L. S., Reis, P. A., Castro-Faria-Neto, H. C., Vainzof, M., & Rosa, M. I. (2019). Neurocognitive Impairment in mdx Mice. Molecular Neurobiology. https://doi.org/10.1007/s12035-019-1573-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.